表紙
市場調查報告書
商品編碼
357516

北美的心律管理設備市場未來展望

North America Cardiac Rhythm Management Devices Market Outlook to 2025 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers

出版日期: | 出版商: GlobalData | 英文 128 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供北美各國 (美國·加拿大·墨西哥) 的心律管理 (CRM) 設備的市場相關分析,提供您地區整體市場趨勢的轉變和預測 (過去·今後8年份),各國水準之詳細趨勢,主要企業·流通管道的市場佔有率,主要的開發中產品之目前臨床實驗情形,近來的市場趨勢,主要企業簡介等調查評估。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 心律管理 (CRM) 設備市場明細
  • 本報告分析對象市場定義

第3章 北美的心律管理設備市場

  • 市場收益額:以金額為準 (總計15年份)
  • 市場收益額:不同分類的比較 (總計15年份)
  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模:以數量為準 (總計15年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 市場收益額佔有率:各企業

第4章 加拿大的心律管理設備市場

  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
    • 置入式除顫器 (ICD):市場收益額的實際成果值 (過去8年份)
    • 心律調節器:市場收益額的實際成果值 (過去8年份)
    • 心臟再同步治療 (CRT):市場收益額的實際成果值 (過去8年份)
    • 置入式除顫器 (ICD):市場收益額的預測值 (今後8年份)
    • 心律調節器:市場收益額的預測值 (今後8年份)
    • 心臟再同步治療 (CRT):市場收益額的預測值 (今後8年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
    • 置入式除顫器 (ICD):市場規模的實際成果值 (過去8年份)
    • 心律調節器:市場規模的實際成果值 (過去8年份)
    • 心臟再同步治療 (CRT):市場規模的實際成果值 (過去8年份)
    • 置入式除顫器 (ICD):市場規模的預測值 (今後8年份)
    • 心律調節器:市場規模的預測值 (今後8年份)
    • 心臟再同步治療 (CRT):市場規模的預測值 (今後8年份)
  • 平均價格趨勢·預測 (總計15年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第5章 墨西哥的心律管理設備市場

第6章 美國的心律管理設備市場

第7章 主要企業概要:北美的心律管理設備市場

  • Medtronic plc
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG

第8章 心律管理設備市場開發中產品

第9章 近幾年的市場趨勢

  • 來自企業的發表 (corporate·通訊) (全16件)
  • 公佈財報 (全21件)
  • 政府·公益相關 (1件)
  • 法規·規定相關 (全5件)
  • 其他主要動向 (全4件)
  • 產品新聞 (1件)
  • 策略·產業計畫 (全2件)

第10章 附錄

圖表一覽

目錄
Product Code: GDMECR1551DB

GlobalData's "North America Cardiac Rhythm Management Devices Market Outlook to 2025" is a comprehensive databook report, covering key market data on the North America Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The North America Cardiac Rhythm Management Devices Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2019 company share and distribution share data for Cardiac Rhythm Management Devices Market.
  • Global corporate-level profiles of key companies operating within the North America Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Cardiac Rhythm Management Devices is segmented as follows -

  • Cardiac Resynchronisation Therapy (CRT)
  • Implantable Cardioverter Defibrillators (ICD)
  • Implantable Loop Recorders (ILR)
  • Pacemakers

Reasons to Buy

The North America Cardiac Rhythm Management Devices Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Cardiac Rhythm Management Devices Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Cardiac Rhythm Management Devices Market, North America

  • 3.1 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2015-2025
  • 3.2 Cardiac Rhythm Management Devices Market, North America, Revenue ($m), 2015-2025
  • 3.3 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025
  • 3.4 Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025
  • 3.5 Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), 2019

4 Cardiac Rhythm Management Devices Market, Canada

  • 4.1 Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2015-2025
    • 4.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2015-2025
    • 4.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2015-2025
    • 4.1.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2015-2025
  • 4.2 Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2025
    • 4.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2015-2025
    • 4.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2015-2025
    • 4.2.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2015-2025
  • 4.3 Cardiac Rhythm Management Devices Market, Canada, Average Price ($) , 2015-2025
  • 4.4 Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), 2019
  • 4.5 Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2019

5 Cardiac Rhythm Management Devices Market, Mexico

  • 5.1 Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), 2015-2025
    • 5.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), by Segment, 2015-2025
    • 5.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), by Segment, 2015-2025
    • 5.1.3 Pacemakers Market, Mexico, Revenue ($m), by Segment, 2015-2025
  • 5.2 Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2025
    • 5.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Volume (Units), by Segment, 2015-2025
    • 5.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Volume (Units), by Segment, 2015-2025
    • 5.2.3 Pacemakers Market, Mexico, Volume (Units), by Segment, 2015-2025
  • 5.3 Cardiac Rhythm Management Devices Market, Mexico, Average Price ($) , 2015-2025
  • 5.4 Cardiac Rhythm Management Devices Market, Mexico, Distribution Share by Revenue ($m), 2019
  • 5.5 Cardiac Rhythm Management Devices Market, Mexico, Company Share by Revenue ($m), 2019

6 Cardiac Rhythm Management Devices Market, United States

  • 6.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2015-2025
    • 6.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2015-2025
    • 6.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2015-2025
    • 6.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2015-2025
  • 6.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025
    • 6.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2015-2025
    • 6.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2015-2025
    • 6.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2015-2025
  • 6.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($) , 2015-2025
  • 6.4 Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2019
  • 6.5 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2019

7 Overview of Key Companies in North America Cardiac Rhythm Management Devices Market

  • 7.1 Medtronic Plc
    • 7.1.1 Company Overview
  • 7.2 Abbott Laboratories
    • 7.2.1 Company Overview
  • 7.3 Biotronik AG
    • 7.3.1 Company Overview
  • 7.4 Boston Scientific Corp
    • 7.4.1 Company Overview

8 Cardiac Rhythm Management Devices Market Pipeline Products

9 Recent Developments

  • 9.1 Corporate Communications
    • 9.1.1 Jul 08, 2020: CVRx raises fresh funds to support commercialisation of BAROSTIM NEO
    • 9.1.2 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference
    • 9.1.3 Feb 03, 2020: Surmodics names Nusrath Sultana, MD, as Vice President, Clinical Affairs
    • 9.1.4 Dec 10, 2019: New Menarini CELLSEARCH studies to be presented at San Antonio Breast Cancer Symposium
    • 9.1.5 Dec 05, 2019: Orthofix names Kevin Kenny president of global spine business
    • 9.1.6 Nov 04, 2019: Ventripoint announces appointment of Justin Leushner as CEO and changes to the board of directors
    • 9.1.7 Nov 01, 2019: Orthofix appoints Jon Serbousek as President and Chief Executive Officer
    • 9.1.8 Sep 24, 2019: Jaguar Health to host investor call to provide updates regarding development of Mytesi for the potential follow-on indication of cancer therapy-related diarrhea
    • 9.1.9 Sep 19, 2019: Ventripoint Diagnostics announces Justin Leushner as new President and Management Restructuring
    • 9.1.10 Sep 16, 2019: Stereotaxis announces CFO transition
  • 9.2 Financial Announcements
    • 9.2.1 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
    • 9.2.2 Feb 05, 2020: Surmodics reports first quarter Fiscal 2020 results
    • 9.2.3 Jan 28, 2020: Beckman Coulter's Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance
    • 9.2.4 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
    • 9.2.5 Dec 23, 2019: iRhythm Technologies files quarterly report on form 10-Q for third quarter 2019 and updates guidance for full year 2019
    • 9.2.6 Dec 09, 2019: ImaginAb initiates phase II clinical trial at Penn Medicine
    • 9.2.7 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results
    • 9.2.8 Nov 05, 2019: iRhythm Technologies announces third quarter 2019 financial results
    • 9.2.9 Oct 31, 2019: Surmodics reports fourth quarter fiscal 2019 results and issues fiscal 2020 revenue and EPS Guidance
    • 9.2.10 Oct 28, 2019: Orthofix reports third quarter 2019 results
    • 9.2.11 Oct 23, 2019: Boston Scientific announces results for third quarter 2019
    • 9.2.12 Sep 25, 2019: Katerzia, the first and only amlodipine oral suspension, 1 mg/mL, is now commercially available for pediatric patients 6 years of age and older
    • 9.2.13 Sep 02, 2019: Quantum Genomics Announces Positive FDA Feedback on Phase III Program Design of Firibastat in Resistant Arterial Hypertension
  • 9.3 Government and Public Interest
    • 9.3.1 Sep 09, 2019: Theravance Biopharma reports positive results from phase 1 clinical trial of TD-8236, an investigational, lung-selective, inhaled Pan-Janus Kinase (JAK) inhibitor for inflammatory lung diseases
    • 9.3.2 Sep 05, 2019: New caregiver-reported data further validate the use of the aberrant behavior checklist community: FXS specific (ABC-CFXS) subscales to assess core behavioral symptoms of Fragile X Syndrome (FXS)
    • 9.3.3 Aug 29, 2019: Parker Waichman LLP and The Drakulich Firm File TDF Lawsuit
  • 9.4 Other Significant Developments
    • 9.4.1 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
    • 9.4.2 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol
    • 9.4.3 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica
  • 9.5 Product News
    • 9.5.1 Nov 22, 2019: Stereotaxis CEO to present at the 12th Annual BIOMEDevice San Jose Conference

10 Appendix

List of Tables

  • 1.1 List of Tables
  • Table 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025
  • Table 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020
  • Table 3: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025
  • Table 4: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2025
  • Table 5: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2015-2020
  • Table 6: Cardiac Rhythm Management Devices Market, North America, Volume (Units), 2021-2025
  • Table 7: Cardiac Rhythm Management Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2019
  • Table 8: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2015-2020
  • Table 9: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2021-2025
  • Table 10: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2015-2020
  • Table 11: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2021-2025
  • Table 12: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2015-2020
  • Table 13: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2021-2025
  • Table 14: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2015-2020
  • Table 15: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2021-2025
  • Table 16: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2015-2020
  • Table 17: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2021-2025
  • Table 18: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2015-2020
  • Table 19: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2021-2025
  • Table 20: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2015-2020
  • Table 21: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2021-2025
  • Table 22: Pacemakers Market, Canada, Volume (Units), 2015-2020
  • Table 23: Pacemakers Market, Canada, Volume (Units), 2021-2025
  • Table 24: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2015-2020
  • Table 25: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2021-2025
  • Table 26: Cardiac Rhythm Management Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2019
  • Table 27: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2019
  • Table 28: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2020
  • Table 29: Cardiac Rhythm Management Devices Market, Mexico, Revenue ($m), USD Constant, 2021-2025
  • Table 30: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2015-2020
  • Table 31: Cardiac Resynchronisation Therapy (CRT) Market, Mexico, Revenue ($m), USD Constant, 2021-2025
  • Table 32: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2015-2020
  • Table 33: Implantable Cardioverter Defibrillators (ICD) Market, Mexico, Revenue ($m), USD Constant, 2021-2025
  • Table 34: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2015-2020
  • Table 35: Pacemakers Market, Mexico, Revenue ($m), USD Constant, 2021-2025
  • Table 36: Cardiac Rhythm Management Devices Market, Mexico, Volume (Units), 2015-2020

List of Figures

  • 1.2 List of Figures
  • Figure 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025
  • Figure 2: Cardiac Rhythm Management Devices Market, North America, Revenue ($m), Historic, USD Constant,